The story of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a flood of knock-off medications, significantly impacting its dominance. While certain pharmaceutical companies may try to capitalize on related treatmen